NAPSRX CNPR CHAPTER 21:
PHARMACEUTICAL TERMINOLOGY
A.A.vg-vganswer---dosagevg"ofvgeach"
A.C.vg-vganswer---dosage,vg"beforevgmeals"
AAHPvg-vganswer---
AmericanvgAssociationvgofvgHealthvgPlans,vgincludesvghealthvgmaintenancevgorganizatio
nsvg(HMOs),vgpreferredvgprovidervgorganizationsvg(PPO),vgothervgformsvgofvgmanagedvgc
are,vgandvgutilizationvgreviewvgorganizationsvg(UROs)
absorptionvgratevg-vganswer---
thevgratevgatvgwhichvgavgdrugvgisvgtakenvgintovgavgpersonsvgbloodstreamvgwithvginvgavgspecifi
edvgtimevgperiod.vgcanvgvaryvgbyvgperson.
ACvg-vganswer---AntivgCholinergicvg
;sidevgeffectvg(dryvgmouth,vgblurredvgvision,vgurinaryvgretention,vgetc.)
acceleratedvgapprovalvg-vganswer---
vgCreatedvginvgearlyvg1990's,vganvgexpeditedvgapprovalvgofvgdrugsvgthatvgrepresentvgavgmaj
orvgadvancevginvgaddressingvgseriousvgorvglife-
threateningvgdiseasesvgforvgwhichvgnovgeffectivevgalternativevgtreatmentsvgexist.vg
-
Undervgacceleratedvgapproval,vgthevgFDAvgacceptsvgavgsurrogatevgendpointvgasvgevidenc
evgofvgeffectiveness,vgandvgrequiresvgpost-
marketingvgstudiesvgtovgconfirmvgthevgdrug'svgbenefits
A.C.E.vginhibitorsvg-vganswer---AngiotensinvgConvertingvgEnzymevginhibitors.vg
-
Avgclassvgofvgdrugsvgusedvgtovgtreatvgcardiovascularvgconditionsvgsuchvgasvghypertensionvg
andvgchronicvgheartvgfailure
actionvglettersvg-vganswer---
OFFICIALvgFDAvgRESPONSEvgtovgNDA.vgthevgmessagevgmayvgbevganvgapprovalvgletter,vg
approvablevgletter,vgorvgavgnon-approvablevgletter
activevgmetabolitevg-vganswer---
AvgbiologicalvgactivevgPRODUCTvgofvgavgmedication'svgmetabolism
acutevgillnessvg-vganswer---
avgconditionvgorvgillnessvgthatvgonlyvglastsvgforvgavgshortvgperiodvgofvgtime.vg(e.g.vgcommonvg
cold)
PHARMACEUTICAL TERMINOLOGY
A.A.vg-vganswer---dosagevg"ofvgeach"
A.C.vg-vganswer---dosage,vg"beforevgmeals"
AAHPvg-vganswer---
AmericanvgAssociationvgofvgHealthvgPlans,vgincludesvghealthvgmaintenancevgorganizatio
nsvg(HMOs),vgpreferredvgprovidervgorganizationsvg(PPO),vgothervgformsvgofvgmanagedvgc
are,vgandvgutilizationvgreviewvgorganizationsvg(UROs)
absorptionvgratevg-vganswer---
thevgratevgatvgwhichvgavgdrugvgisvgtakenvgintovgavgpersonsvgbloodstreamvgwithvginvgavgspecifi
edvgtimevgperiod.vgcanvgvaryvgbyvgperson.
ACvg-vganswer---AntivgCholinergicvg
;sidevgeffectvg(dryvgmouth,vgblurredvgvision,vgurinaryvgretention,vgetc.)
acceleratedvgapprovalvg-vganswer---
vgCreatedvginvgearlyvg1990's,vganvgexpeditedvgapprovalvgofvgdrugsvgthatvgrepresentvgavgmaj
orvgadvancevginvgaddressingvgseriousvgorvglife-
threateningvgdiseasesvgforvgwhichvgnovgeffectivevgalternativevgtreatmentsvgexist.vg
-
Undervgacceleratedvgapproval,vgthevgFDAvgacceptsvgavgsurrogatevgendpointvgasvgevidenc
evgofvgeffectiveness,vgandvgrequiresvgpost-
marketingvgstudiesvgtovgconfirmvgthevgdrug'svgbenefits
A.C.E.vginhibitorsvg-vganswer---AngiotensinvgConvertingvgEnzymevginhibitors.vg
-
Avgclassvgofvgdrugsvgusedvgtovgtreatvgcardiovascularvgconditionsvgsuchvgasvghypertensionvg
andvgchronicvgheartvgfailure
actionvglettersvg-vganswer---
OFFICIALvgFDAvgRESPONSEvgtovgNDA.vgthevgmessagevgmayvgbevganvgapprovalvgletter,vg
approvablevgletter,vgorvgavgnon-approvablevgletter
activevgmetabolitevg-vganswer---
AvgbiologicalvgactivevgPRODUCTvgofvgavgmedication'svgmetabolism
acutevgillnessvg-vganswer---
avgconditionvgorvgillnessvgthatvgonlyvglastsvgforvgavgshortvgperiodvgofvgtime.vg(e.g.vgcommonvg
cold)
